Northwire Canada EditionSaturday, July 11, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
Earnings Routine +

Herbal Dispatch Reports Q4 2025 Gross Sales of $6.2 Million, Achieves Positive Adjusted EBITDA, and Reports Full Year Gross Sales of $16.5 Million

Herbal Dispatch Posts Q4 Profit, Yet Full-Year Loss Persists Amidst Cannabis Sector Volatility

By The Northwire Desk — AI Analysis Apr 24, 2026 · 03:02 HERB · 0.055 Herbal Dispatch Inc.
Executive Summary
  • Herbal Dispatch Inc. reported Q4 2025 gross sales of $6.2 million, representing a 115% year-over-year increase from Q4 2024.
  • Full Year 2025 gross sales reached $16.5 million, up 37% from the previous fiscal year.
  • The company achieved positive Adjusted EBITDA of $0.1 million in Q4 2025, a significant turnaround from -$0.6 million in Q4 2024.
  • Full Year 2025 Adjusted EBITDA remained negative at -$0.7 million, though improved from -$1.0 million in 2024.
  • Gross margins expanded to 22.7% for FY 2025 compared to 20.1% in 2024.
  • The company completed an oversubscribed private placement raising $2.1 million in October 2025, with proceeds allocated to inventory and export expansion.
  • Shares are now eligible for DTC clearing and have a market maker engaged at Independent Trading Group Inc.
Material Impact
  • Sales Guidance Miss: The Q4 sales of $6.2 million fell slightly below the upper end of the previously raised guidance range ($6.4M-$7.0M announced in November 2025), tempering immediate upside expectations despite strong YoY growth.
  • Profitability Milestone: Achieving positive Adjusted EBITDA in Q4 is a critical operational milestone, validating the cost control and margin expansion strategies outlined in the 2026 Strategic Business Plan.
  • Capital Position: The $2.1 million private placement provides sufficient runway for growth initiatives into 2026, reducing immediate dilution risk compared to previous financing rounds.
  • Market Sentiment: Despite positive earnings, the stock price has declined from a high of $0.12 in February 2026 to $0.05 in April 2026, suggesting the market may have already priced in growth or remains cautious about full-year profitability.
  • Rating Justification: The news confirms the company's trajectory but does not introduce unexpected catalysts that would fundamentally alter the risk profile; hence it is Routine - Positive rather than Material.
HERB · Price
Company Overview
  • Company: Herbal Dispatch Inc. operates as a craft cannabis distributor in Canada with expanding international export operations.
  • Flagship Project: The core business model relies on direct-to-consumer sales via e-commerce and wholesale distribution across Canadian provinces, supplemented by high-margin medical cannabis exports to Europe (Germany/Portugal) and other markets.
  • Development Status: Currently scaling operations following a successful private placement; transitioning from growth-focused loss-making to profitability-focused operations as evidenced by Q4 EBITDA turnaround.
  • Market Presence: Listed on CSE (HERB), Frankfurt Stock Exchange (HA9), and OTCQB Venture Market (LUFFF).
Read the original news release →

More from Herbal Dispatch Inc.

Jun 16, 2026 · 03:02

Herbal Dispatch Provides Update on Domestic Retail Operations and Proprietary Brand Expansion

Production / Operations Jun 09, 2026 · 03:02

Herbal Dispatch Completes 452kg Multi Client Medical Cannabis Export Shipment To Europe

Production / Operations Jun 01, 2026 · 03:01

Herbal Dispatch Reports First Quarter 2026 Results and Provides Business Update

Earnings May 26, 2026 · 05:02

EDC Insurance De-risks Export Pipeline as Revenue Growth Outpaces Profitability

Production / Operations May 21, 2026 · 08:45

Export Momentum Validates Strategy But Net Losses and Debt Costs Remain Key Risks

Production / Operations May 21, 2026 · 05:02

Herbal Dispatch Exports Surge to 761kg in Week as European Strategy Validates, Yet Profitability Remains Elusive

Production / Operations